DNAH8 antisense RNA 1 (DNAH8-AS1)

DNAH8 antisense RNA 1 (DNAH8-AS1), also referred to as lnc-SAYSD1-1, is a long non-coding antisense RNA gene located on the DNA strand opposite to the protein-coding DNAH8 gene. As a member of the long non-coding antisense RNA class, it is presumed to function mainly by regulating the expression of its sense (protein-coding) partner gene or local chromatin structure through cis-acting transcriptional mechanisms typical of many antisense lncRNAs[2][4][6]. There is currently no evidence that DNAH8-AS1 serves as a direct therapeutic target, nor are there confirmed drug interactions, disease biomarker utility, or known adverse safety concerns linked specifically to this RNA. Explanation & Context: - DNAH8-AS1 is a long non-coding RNA (lncRNA) classified specifically as an antisense RNA, meaning it is transcribed from the strand opposite of the protein-coding DNAH8 gene, and is considered a member of the antisense RNA class under human gene nomenclature conventions[1][4][6]. - Its known aliases are "lnc-SAYSD1-1" and "DNAH8-AS1"[4]. - While many antisense lncRNAs regulate gene expression by acting in cis (locally at their site of synthesis), the specific biological and disease roles of DNAH8-AS1 have not, as of the latest available data, been definitively characterized[1][4][6]. - There is no current evidence designating DNAH8-AS1 as a therapeutic target, nor are drugs or safety issues associated with its manipulation reported in the biomedical literature[1][4]. - Its regulatory mechanism—by analogy to related antisense lncRNAs—is likely chromatin-mediated modulation of neighboring gene expression, but this has not been directly established for DNAH8-AS1[2].

Other names

lnc-SAYSD1-1DNAH8-AS1[1][4]